M. W. Dercksen

1.2k total citations
20 papers, 971 citations indexed

About

M. W. Dercksen is a scholar working on Oncology, Epidemiology and Hematology. According to data from OpenAlex, M. W. Dercksen has authored 20 papers receiving a total of 971 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 5 papers in Epidemiology and 5 papers in Hematology. Recurrent topics in M. W. Dercksen's work include Cancer Treatment and Pharmacology (5 papers), Neuroendocrine Tumor Research Advances (4 papers) and Platelet Disorders and Treatments (4 papers). M. W. Dercksen is often cited by papers focused on Cancer Treatment and Pharmacology (5 papers), Neuroendocrine Tumor Research Advances (4 papers) and Platelet Disorders and Treatments (4 papers). M. W. Dercksen collaborates with scholars based in Netherlands and United States. M. W. Dercksen's co-authors include H. M. Pinedo, Frank Miedema, Matthijs Tersmette, Maarten Koot, René Keet, Fokke G. Terpstra, R. E. Y. de Goede, Roel A. Coutinho, Sjoerd Rodenhuis and CE van der Schoot and has published in prestigious journals such as Journal of Clinical Oncology, Blood and British Journal of Cancer.

In The Last Decade

M. W. Dercksen

19 papers receiving 945 citations

Peers

M. W. Dercksen

HEMAT

VIROL

ONCOL

IMMUN

Joseph Alvarnas United States

A Zander Germany

DT Scadden United States

J Mimaya Japan

Ellen G. van Lochem Netherlands

RK Brynes United States

JL Abkowitz United States

Neil Kogut United States

Francesca Mazzetta Italy

Steve Ziesmer United States

Joseph Alvarnas United States

M. W. Dercksen

174 ×0.5

HEMAT

175 ×0.6

VIROL

342 ×1.2

ONCOL

144 ×0.6

IMMUN

86 ×0.4

Citations per year, relative to M. W. Dercksen M. W. Dercksen (= 1×) peers Joseph Alvarnas

Countries citing papers authored by M. W. Dercksen

Since Specialization

Citations

This map shows the geographic impact of M. W. Dercksen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. W. Dercksen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. W. Dercksen more than expected).

Fields of papers citing papers by M. W. Dercksen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. W. Dercksen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. W. Dercksen. The network helps show where M. W. Dercksen may publish in the future.

Co-authorship network of co-authors of M. W. Dercksen

This figure shows the co-authorship network connecting the top 25 collaborators of M. W. Dercksen. A scholar is included among the top collaborators of M. W. Dercksen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. W. Dercksen. M. W. Dercksen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Geurts, Sandra M. E., J. Tol, Birgit E. P. J. Vriens, et al.. (2024). 202P Complete response rates, treatment patterns and survival outcomes in patients treated with first-line pertuzumab-based therapy in HER2-positive advanced breast cancer: A SONABRE study. ESMO Open. 9. 103224–103224. 1 indexed citations

Geurts, Sandra M. E., et al.. (2023). Case series of metastatic breast cancer patients with visceral crisis treated with CDK4/6 inhibitors. Journal of Chemotherapy. 36(4). 343–350. 1 indexed citations

Ramaekers, Bram, D.J.A. Lobbezoo, Roel J.W. van Kampen, et al.. (2020). Quality of life in a real-world cohort of advanced breast cancer patients: a study of the SONABRE Registry. Quality of Life Research. 29(12). 3363–3374. 14 indexed citations

Vos‐Geelen, Judith de, Jules L. Derks, Ing Han Liem, et al.. (2020). Unique Metastatic Patterns in Neuroendocrine Neoplasms of Different Primary Origin. Neuroendocrinology. 111(11). 1111–1120. 17 indexed citations

Samsom, Kris G., Paul Roepman, Liudmila L. Kodach, et al.. (2020). Driver mutations occur frequently in metastases of well‐differentiated small intestine neuroendocrine tumours. Histopathology. 78(4). 556–566. 13 indexed citations

Leclercq, Wouter K. G., et al.. (2019). Paraganglion, a pitfall in diagnosis after regular cholecystectomy. International Journal of Surgery Case Reports. 65(C). 205–208. 1 indexed citations

Pouwels, Xavier, Sandra M. E. Geurts, Bram Ramaekers, et al.. (2019). The relative effectiveness of eribulin for advanced breast cancer treatment: a study of the southeast Netherlands advanced breast cancer registry. Acta Oncologica. 59(1). 82–89. 5 indexed citations

Lobbezoo, D.J.A., Roel J.W. van Kampen, Adri C. Voogd, et al.. (2015). Prognosis of metastatic breast cancer: are there differences between patients with de novo and recurrent metastatic breast cancer?. British Journal of Cancer. 112(9). 1445–1451. 169 indexed citations

Stelten, Bianca M. L., et al.. (2014). Two patients with a neuroendocrine tumour of the small intestine and paraneoplastic myasthenia gravis. Endocrinology Diabetes and Metabolism Case Reports. 2014. 140013–140013. 2 indexed citations

10.

Hermsen, I G C, et al.. (2010). Response to radiation therapy in adrenocortical carcinoma. Journal of Endocrinological Investigation. 33(10). 712–714. 28 indexed citations

11.

Oever, Jaap ten, P. H. M. Kuijper, A.L.A. Kuijpers, M. W. Dercksen, & Gerard Vreugdenhil. (2009). Complete remission of MDS RAEB following immunosuppressive treatment in a patient with Sweet's syndrome.. PubMed. 67(8). 347–50. 12 indexed citations

12.

Bosch, Jules M.M. van den, et al.. (2005). [Haemoptysis as a complication of Behçet's disease].. PubMed. 149(29). 1631–5.

13.

Rood, Pauline M.L., M. W. Dercksen, JM Kerst, et al.. (2000). E-selectin and very late activation antigen-4 mediate adhesion of hematopoietic progenitor cells to bone marrow endothelium. Annals of Hematology. 79(9). 477–484. 15 indexed citations

14.

Dercksen, M. W., Sjoerd Rodenhuis, W. P. Schaasberg, et al.. (1995). Subsets of CD34+ cells and rapid hematopoietic recovery after peripheral-blood stem-cell transplantation.. Journal of Clinical Oncology. 13(8). 1922–1932. 124 indexed citations

15.

Dercksen, M. W., Sjoerd Rodenhuis, IC Slaper-Cortenbach, et al.. (1995). Expression of adhesion molecules on CD34+ cells: CD34+ L-selectin+ cells predict a rapid platelet recovery after peripheral blood stem cell transplantation. Blood. 85(11). 3313–3319. 175 indexed citations

16.

Dercksen, M. W., J Breton-Gorius, William Vainchenker, et al.. (1995). The value of flow cytometric analysis of platelet glycoprotein expression of CD34+ cells measured under conditions that prevent P- selectin-mediated binding of platelets. Blood. 86(10). 3771–3782. 73 indexed citations

17.

Schoot, C. Ellen van der & M. W. Dercksen. (1994). MOBILIZATION AND HOMING OF HAEMATOPOIETIC PROGENITOR CELLS. Vox Sanguinis. 67(s3). 221–226. 5 indexed citations

18.

Huinink, W.W. ten Bokkel, M. W. Dercksen, & Harm van Tinteren. (1994). Further studies to ameliorate toxicity of carboplatin.. PubMed. 21(2 Suppl 2). 27–33; quiz 34, 58. 4 indexed citations

19.

Dercksen, M. W., Klaas Hoekman, R. Dubbelman, et al.. (1993). Effects of interleukin-3 on myelosuppression induced by chemotherapy for ovarian cancer and small cell undifferentiated tumours. British Journal of Cancer. 68(5). 996–1003. 11 indexed citations

20.

Koot, Maarten, René Keet, R. E. Y. de Goede, et al.. (1992). HIV-1 biological phenotype in long-term infected individuals evaluated with an MT-2 cocultivation assay. AIDS. 6(1). 49–54. 301 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact